“Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”

Bade, Brett C.; Gan, Geliang; Li, Fangyong; Lu, Lingeng; Tanoue, L.T.; Silvestri, Gerard A.; Irwin, Melinda L.

doi:10.1186/s12885-021-08084-0

Cited by 37 publications

(68 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After reading the full texts, 21 studies were included in the final analysis. 18 , 19 , 21 , 23 – 40 See Figure 1 for the flowchart of the detailed screening process.…”

Section: Resultsmentioning

confidence: 99%

The efficacy of telemedicine for pain management in patients with cancer: a systematic review and meta-analysis

Chen

Huang

Cui

et al. 2023

Therapeutic Advances in Chronic Disease

View full text Add to dashboard Cite

Background: Pain is the most common cancer-related symptom, but it is often undertreated. Telemedicine is widely used in cancer treatment, but its effectiveness is uncertain. Objective: We aimed to evaluate the impact of telemedicine intervention on pain in patients with cancer. Design: Methodological quality and risk-of-bias evaluation were conducted, and the sources of heterogeneity were explored through subgroup analysis and sensitivity analysis. Data Sources and Methods: PubMed, Embase, Web of Science, Cochrane Library, and clinical trial databases were searched up to 16 August 2022. Randomized controlled trials of the impact of telemedicine intervention regarding pain in patients with cancer were included, and the results related to pain were extracted. Results: Twenty-one randomized controlled trials were selected from 1810 articles. A total of 1454 patients received telemedicine interventions, and 2213 received conventional medical services. Telemedical intervention had a positive effect on improving pain intensity [standard mean deviation (SMD) = −0.28, 95% confidence interval (CI): −0.49 to −0.06, p = 0.01] and pain interference (SMD = −0.41, 95% CI: −0.54 to −0.28, p < 0.00001), with statistical difference between the two groups. The subgroup analysis results showed that the telemedicine subgroup based on an application (SMD = −0.54, 95% CI: −0.91 to −0.18, p = 0.004) and the subgroup with intervention time ⩾ 6 months (SMD = −0.33, 95% CI: −0.52 to −0.13, p = 0.001), both demonstrated significant improvement regarding pain intensity, with significant statistical difference between the two groups. When the follow-up time was ⩾ 6 months, there was no significant difference (SMD = −0.24, 95% CI: −0.55 to 0.07, p = 0.13). Conclusion: Compared with conventional medical services, telemedicine intervention can improve the pain of patients with cancer and is effective and acceptable regarding symptom monitoring. Integrating telemedicine interventions into cancer pain management may be a feasible option. But its long-term effects still need to be confirmed with more high-quality randomized controlled trials in the future. Registration: https://www.crd.york.ac.uk/PROSPERO/ ; CRD42022361990

show abstract

“…After reading the full texts, 21 studies were included in the final analysis. 18 , 19 , 21 , 23 – 40 See Figure 1 for the flowchart of the detailed screening process.…”

Section: Resultsmentioning

confidence: 99%

The efficacy of telemedicine for pain management in patients with cancer: a systematic review and meta-analysis

Chen

Huang

Cui

et al. 2023

Therapeutic Advances in Chronic Disease

View full text Add to dashboard Cite

show abstract

“…National policies should further focus on reducing cancer incidence and preventing disability. For example, lifestyle interventions, including diet and physical activity when combined with chemotherapy can enhance treatment efficacy [21,22], or different types of counseling, psychoeducation or therapy can help with cancer-related fatigue [23].…”

Section: Discussionmentioning

confidence: 99%

The non-fatal burden of cancer in Belgium, 2004–2019: a nationwide registry-based study

Gorasso

Silversmit²,

Arbyn

et al. 2022

BMC Cancer

View full text Add to dashboard Cite

Background The importance of assessing and monitoring the health status of a population has grown in the last decades. Consistent and high quality data on the morbidity and mortality impact of a disease represent the key element for this assessment. Being increasingly used in global and national burden of diseases (BoD) studies, the Disability-Adjusted Life Year (DALY) is an indicator that combines healthy life years lost due to living with disease (Years Lived with Disability; YLD) and due to dying prematurely (Years of Life Lost; YLL). As a step towards a comprehensive national burden of disease study, this study aims to estimate the non-fatal burden of cancer in Belgium using national data. Methods We estimated the Belgian cancer burden from 2004 to 2019 in terms of YLD, using national population-based cancer registry data and international disease models. We developed a microsimulation model to translate incidence- into prevalence-based estimates, and used expert elicitation to integrate the long-term impact of increased disability due to surgical treatment. Results The age-standardized non-fatal burden of cancer increased from 2004 to 2019 by 6 and 3% respectively for incidence- and prevalence-based YLDs. In 2019, in Belgium, breast cancer had the highest morbidity impact among women, followed by colorectal and non-melanoma skin cancer. Among men, prostate cancer had the highest morbidity impact, followed by colorectal and non-melanoma skin cancer. Between 2004 and 2019, non-melanoma skin cancer significantly increased for both sexes in terms of age-standardized incidence-based YLD per 100,000, from 49 to 111 for men and from 15 to 44 for women. Important decreases were seen for colorectal cancer for both sexes in terms of age-standardized incidence-based YLD per 100,000, from 105 to 84 for men and from 66 to 58 for women. Conclusions Breast and prostate cancers represent the greatest proportion of cancer morbidity, while for both sexes the morbidity burden of skin cancer has shown an important increase from 2004 onwards. Integrating the current study in the Belgian national burden of disease study will allow monitoring of the burden of cancer over time, highlighting new trends and assessing the impact of public health policies.

show abstract

“…The review also indicates a significant bias in terms of the sample and respondents (see Appendix 1, Figure 4). Prior studies seemed to have majorly focused on females [36,78,98,114] and respondents of Caucasian ethnicity [21,84,91]. Few studies have studied the effects of mHealth interventions on vulnerable sections of the population, such as immigrants [79], or ethnic groups such as Koreans [114] or Chinese Americans [107].…”

Section: Theme 3: Methodological Approachmentioning

confidence: 99%

“…Moreover, prior research has suggested a degree of fragmentation in prior research designs and methodologies. For example, some studies have focused on understanding cancer management in specific demographic profile cohorts, such as elderly or older [35][36][37] or adolescent [34,38,39] populations, while others have focused on elucidating mHealth interventions for patients afflicted with a specific form of cancer, such as colorectal cancer [40] or breast cancer [41]. This widespread fragmentation indicates the need to amalgamate the prior research to identify the limitations in the present knowledge, incumbent gaps, and scope for future research through the use of systematic literature reviews (SLRs).…”

Section: Introductionmentioning

confidence: 99%

Mobile Health Interventions for Cancer Care and Support: The Next Level of Digitalization in Healthcare?

Tandon¹,

Dhir

Islam

2024

IEEE Trans. Eng. Manage.

View full text Add to dashboard Cite

Academic research has brought attention to the utility of mobile health (mHealth) interventions for assisting cancer patients and survivors in managing their medication, symptoms, and well-being. This is a vital research area, as cancer is the second main cause of death for the global populace. However, the knowledge on mHealth interventions for cancer is distinctly fragmented and there is a lack of clarity on its boundaries, which hinders identification of existing gaps and valuable areas in which to advance future research. Our study addresses this gap and provides a comprehensive review of extant literature to determine the core areas of discourse. This systematic literature review (SLR) amalgamates the extant findings related to users' (cancer patients, cancer survivors, healthcare providers, and clients) experiences of mHealth interventions. Following rigorous protocols, we reviewed pertinent literature from Scopus and Web of Science databases to curate 78 studies. Grounded theory was adopted as an analytical framework and content analysis was used to explicate state-of-the-art insights. To our knowledge, this is the most comprehensive SLR on this topic. The findings revealed four themes and incumbent gaps: (i) intervention targets and affordances, (ii) individual outcomes, (iii) methodological approaches, and (iv) intervention resistance or adoption. Our findings contribute to theory by proposing key areas for meaningful future research. Additionally, our findings provide crucial inputs to practitioners, such as app developers and healthcare personnel, to improve user engagement with mHealth interventions.

show abstract

“Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”

Cited by 37 publications

References 54 publications

The efficacy of telemedicine for pain management in patients with cancer: a systematic review and meta-analysis

The efficacy of telemedicine for pain management in patients with cancer: a systematic review and meta-analysis

The non-fatal burden of cancer in Belgium, 2004–2019: a nationwide registry-based study

Mobile Health Interventions for Cancer Care and Support: The Next Level of Digitalization in Healthcare?

Contact Info

Product

Resources

About